These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28679652)

  • 1. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.
    De Clara E; Gourvest M; Ma H; Vergez F; Tosolini M; Dejean S; Demur C; Delabesse E; Recher C; Touriol C; Martelli MP; Falini B; Brousset P; Bousquet M
    Haematologica; 2017 Oct; 102(10):1718-1726. PubMed ID: 28679652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
    Papaioannou D; Nicolet D; Volinia S; Mrózek K; Yan P; Bundschuh R; Carroll AJ; Kohlschmidt J; Blum W; Powell BL; Uy GL; Kolitz JE; Wang ES; Eisfeld AK; Orwick SJ; Lucas DM; Caligiuri MA; Stone RM; Byrd JC; Garzon R; Bloomfield CD
    Haematologica; 2017 Aug; 102(8):1391-1400. PubMed ID: 28473620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
    Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
    J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.
    Garciaz S; N'guyen Dasi L; Finetti P; Chevalier C; Vernerey J; Poplineau M; Platet N; Audebert S; Pophillat M; Camoin L; Bertucci F; Calmels B; Récher C; Birnbaum D; Chabannon C; Vey N; Duprez E
    Clin Epigenetics; 2019 Oct; 11(1):141. PubMed ID: 31606046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
    Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
    Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
    Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
    Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-mRNA Profiling Reveals Prognostic Impact of
    Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
    Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
    Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
    J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
    Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
    Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
    Haferlach C; Mecucci C; Schnittger S; Kohlmann A; Mancini M; Cuneo A; Testoni N; Rege-Cambrin G; Santucci A; Vignetti M; Fazi P; Martelli MP; Haferlach T; Falini B
    Blood; 2009 Oct; 114(14):3024-32. PubMed ID: 19429869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.
    Alarbeed IF; Wafa A; Moassass F; Al-Halabi B; Alachkar W; Aboukhamis I
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):227-232. PubMed ID: 33507703
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
    Turk J Haematol; 2018 Mar; 35(1):49-53. PubMed ID: 29129825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
    Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.
    Peterlin P; Renneville A; Ben Abdelali R; Nibourel O; Thomas X; Pautas C; de Botton S; Raffoux E; Cayuela JM; Boissel N; Terré C; Celli-Lebras K; Castaigne S; Preudhomme C; Gardin C; Dombret H
    Haematologica; 2015 May; 100(5):e196-9. PubMed ID: 25552703
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA.
    Gourvest M; De Clara E; Wu HC; Touriol C; Meggetto F; De Thé H; Pyronnet S; Brousset P; Bousquet M
    Leukemia; 2021 Oct; 35(10):2784-2798. PubMed ID: 34131282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse.
    Jain P; Kantarjian H; Patel K; Faderl S; Garcia-Manero G; Benjamini O; Borthakur G; Pemmaraju N; Kadia T; Daver N; Nazha A; Luthra R; Pierce S; Cortes J; Ravandi F
    Leuk Lymphoma; 2014 Jun; 55(6):1337-44. PubMed ID: 24004182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal/Measurable Residual Disease Monitoring in
    Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
    Walker CJ; Mrózek K; Ozer HG; Nicolet D; Kohlschmidt J; Papaioannou D; Genutis LK; Bill M; Powell BL; Uy GL; Kolitz JE; Carroll AJ; Stone RM; Garzon R; Byrd JC; Eisfeld AK; de la Chapelle A; Bloomfield CD
    Blood Adv; 2021 Mar; 5(5):1474-1482. PubMed ID: 33683341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
    Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.